Operates drug stores offering pharmaceuticals, health and beauty products, and over-the-counter medications. Now — the numbers.
This is an established company with proven profits.
Average growth of 7% a year over the last 4 years. Every year shown ended in profit.
If every debt were paid off today, $146.1M would still be left in the vault — a solid cushion for hard times.
The market pays 16× for every dollar of annual profit — around what a business like this usually costs.
No analyst target is on record for this company.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Trading Liquidity: The shares change hands too rarely for smooth trading.
The stock trades below its recent peak — about 11% off the top. A pullback, not a collapse.
There is $461.8M in the vault; even if every debt were paid off, $146.1M would remain.
Getting in and out without moving the price could prove difficult. Council score: 2/10.
Costs swallow the gains that sales growth brings in. Council score: 4/10.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.